News

Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17
HUMACAO, PR AND NEW YORK, NY / ACCESS Newswire / April 14, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the ...
Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement
Headquartered in Humacao, Puerto Rico, Aspire Biopharma has developed a disruptive technology through a novel soluble formulation which addresses emergencies, drug efficacy, dosage management, and ...
Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
One clinical trial site activated Patient enrollment expected in April Trial designed to evaluate safety, pharmacokinetics ...